Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height

Oncotarget

Volumn 2, Issue 12, 2011, Pages 1127-1133

  Tatton Brown, Katrina ^a,b   Hanks, Sandra ^a   Ruark, Elise ^a   Zachariou, Anna ^a   Duarte, Silvana Del Vecchio ^a   Ramsay, Emma ^a   Snape, Katie ^a   Murray, Anne ^a   Perdeaux, Elizabeth R ^a   Seal, Sheila ^a   Loveday, Chey ^a   Banka, Siddharth ^c   Clericuzio, Carol ^d   Flinter, Frances ^e   Magee, Alex ^f   McConnell, Vivienne ^f   Patton, Michael ^b   Raith, Wolfgang ^g   Rankin, Julia ^h   Splitt, Miranda ⁱ   Strenger, Volker ^j   Taylor, Clare ^k   Wheeler, Patricia ^l   Temple, I Karen ^m   Cole, Trevor ⁿ   Douglas, Jenny ^a   Rahman, Nazneen ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f BELFAST CITY HOSPITAL   (United Kingdom)

^g Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

^h ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

ⁱ INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

^k UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^l Division of Genetics   (United States)

^m UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁿ BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

more..

Author keywords

EZH2; Height; Histone methyltransferase; Myeloid malignancies; Weaver syndrome

Indexed keywords

DNA BINDING PROTEIN; EZH2 PROTEIN, HUMAN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BODY HEIGHT; CONGENITAL HYPOTHYROIDISM; CRANIOFACIAL MALFORMATION; DNA SEQUENCE; FACIES; FEMALE; GENETICS; GROWTH DISORDER; HAND MALFORMATION; HUMAN; MALE; MULTIPLE MALFORMATION SYNDROME; MUTATION; WEAVER SYNDROME;

ABNORMALITIES, MULTIPLE; AMINO ACID SEQUENCE; BODY HEIGHT; CONGENITAL HYPOTHYROIDISM; CRANIOFACIAL ABNORMALITIES; DNA-BINDING PROTEINS; FACIES; FEMALE; GERM-LINE MUTATION; GROWTH DISORDERS; HAND DEFORMITIES, CONGENITAL; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; MALE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84863795741     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.385     Document Type: Article

References (29)

1. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segre AV, Speliotes EK, Wheeler E et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010; 467:832-838.
2. Weaver DD, Graham CB, Thomas IT, Smith DW. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. J Pediatr. 1974; 84:547- 552.
3. Cole TR, Dennis NR, Hughes HE. Weaver syndrome. J Med Genet. 1992; 29:332-337.
4. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, Waghorn K, Zoi K, Ross FM, Reiter A, Hochhaus A, Drexler HG, Duncombe A, Cervantes F, Oscier D, Boultwood J et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet. 2010; 42:722-726.
5. Chase A, Cross NC. Aberrations of EZH2 in cancer. Clin Cancer Res. 2011; 17:2613-2618.
6. Patton M: Genetic and Dysmorphic syndromes of Tall Stature. In: Growth Disorders - Pathophysiology and Treatment Edited by Kelnar, Stirling, Savage, Second edn: Chapman & Hall; 1998.
7. Dumic M, Vukovic J, Cvitkovic M, Medica I. Twins and their mildly affected mother with Weaver syndrome. Clin Genet. 1993; 44:338-340.
8. Fryer A, Smith C, Rosenbloom L, Cole T. Autosomal dominant inheritance of Weaver syndrome. J Med Genet. 1997; 34:418-419.
9. Proud VK, Braddock SR, Cook L, Weaver DD. Weaver syndrome: autosomal dominant inheritance of the disorder. Am J Med Genet. 1998; 79:305-310.
10. Snape K, Hanks S, Ruark E, Barros-Nunez P, Elliott A, Murray A, Lane AH, Shannon N, Callier P, Chitayat D, Clayton-Smith J, Fitzpatrick DR, Gisselsson D, Jacquemont S, Asakura-Hay K, Micale MA et al. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat Genet. 2011; 43:527-529.
11. Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev. 2004; 14:155-164.
12. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Fuks F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006; 439:871-874.
13. Chou RH, Yu YL, Hung MC. The roles of EZH2 in cell lineage commitment. Am J Transl Res. 2011; 3:243-250.
14. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010; 42:181-185.
15. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tonnissen ER, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet [2010;] 42:665-667.
16. Sneeringer CJ, Scott MP, Kuntz KW, Knutson SK, Pollock RM, Richon VM, Copeland RA. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci U S A. 2010; 107:20980-20985.
17. Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole TR, Das S, Horn D, Hughes HE, Temple IK, Faravelli F, Waggoner D, Turkmen S, Cormier-Daire V, Irrthum A, Rahman N. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet. 2005; 77:193-204.
18. Mester JL, Tilot AK, Rybicki LA, Frazier TW, 2nd, Eng C. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet. 2011; 19:763-768.
19. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011.
20. Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, Turner J, Cannons JL, Bick D, Blakemore L, Blumhorst C, Brockmann K, Calder P, Cherman N, Deardorff MA, Everman DB et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med. 2011; 365:611-619.
21. Greenberg F, Wasiewski W, McCabe ER. Weaver syndrome: the changing phenotype in an adult. Am J Med Genet. 1989; 33:127-129.
22. Child Growth Foundation UK: The British 1990 growth reference. Revised September 1996. In.: Child Growth Foundation, 2 Mayfield Avenue, London W4 1PW, UK.
23. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002; 30:3894-3900.
24. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001; 11:863-874.
25. Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol. 1997; 4:311- 323.
26. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004; 11:377-394.
27. Brunak S, Engelbrecht J, Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol. 1991; 220:49-65.
28. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009; 37:e67.
29. Burge C, Karlin S. Prediction of complete gene structures in human genomic DNA. J Mol Biol. 1997; 268:78-94.